A novel protein platform helps neutralize powerful MRSA toxins.
We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.
Harvard Medical School’s Richard Sherwood digs into the potential and pitfalls of gene editing technology.
How DNA origami nanostructures could find their way into the treatment of acute kidney injury.
Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse.
We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.
A new method for discovering antibiotics makes use of an unusual source of complex microbial communities: bear saliva.
Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.
Could activated T cells play a major role in driving neurodegeneration in glaucoma?
A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
You will benefit from:
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal